AIL
RARE icon

AGF Investments LLC’s Ultragenyx Pharmaceutical RARE Stock Holding History

AGF Investments LLC’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-180
Closed -$25K – 491
2020
Q4 		$25K Buy
+180
New +$21.4K ﹤0.01% 371
2018
Q4 		– Sell
-106
Closed -$8K – 796
2018
Q3 		$8K Sell
106
-130
-55% -$10.6K ﹤0.01% 744
2018
Q2 		$18 Buy
+236
New +$15.2K ﹤0.01% 665
2017
Q3 		– Sell
-152
Closed -$10K – 798
2017
Q2 		$10K Buy
152
+20
+15% +$1.21K ﹤0.01% 529
2017
Q1 		$9K Sell
132
-2
-1% -$152 ﹤0.01% 629
2016
Q4 		$10K Buy
+134
New +$9.51K ﹤0.01% 622

Other funds holding RARE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

AGF Investments LLC's RARE Position: Q1 2021 in Review

AGF Investments LLC sold out of Ultragenyx Pharmaceutical (RARE) in Q1 2021, closing a stake of 180 shares — an estimated $25K sold.

AGF Investments LLC first reported a position in RARE in Q4 2016 and held it in 6 quarters. The position peaked at $25K in Q4 2020. 254 funds tracked by Wall St. Rank hold RARE as of Q1 2021.

  • AGF Investments LLC reported no remaining Ultragenyx Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • AGF Investments LLC sold 180 Ultragenyx Pharmaceutical shares in Q1 2021, an estimated $25K.
  • AGF Investments LLC first reported a position in Ultragenyx Pharmaceutical in Q4 2016 and held it in 6 quarters.
  • AGF Investments LLC's Ultragenyx Pharmaceutical position peaked at $25K in Q4 2020.
  • 254 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2021.

Based on AGF Investments LLC's 13F filing for Q1 2021, filed 14 May 2021.